Business
Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug Discovery
The company aims to hire up to 50 people by the end of 2021 across disciplines of data science, machine learning, engineering, product management and
About this update from Recursion Pharmaceuticals, Inc.
[{"type":"text","content":"The company aims to hire up to 50 people by the end of 2021 across disciplines of data science, machine learning, engineering, product management and computational biology.\n TORONTO, June 15, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its intention to soon launch its first major multidisciplinary expansion beyond its Utah headquarters, with plans to hire up to 50 people in Toronto by the end of 2021. \n\n \n \n \n \n \n \n\n \n\"As Recursion continues to build a next-generation biopharma company, it's critical that we hire the best talent,\" said Co-Founder & CEO Chris Gibson, Ph.D. \"Toronto stood out as an ideal location for our first hub beyond our headquarters because of its diverse and brilliant talent across technology, biology and chemistry. I look forward to expanding our operations in Canada and hiring many new Recursionauts that will help us advance our mission of decoding biology to radically improve lives through continued development of the Recursion OS, as well as advancement and expansion of what is already the largest, broadest and deepest therapeutic pipeline of any technology-enabled drug discovery company.\"\nToday, Recursion has over 260 employees across biology, chemistry, automation, data science, machine learning, engineering and accelerating functions. Over the past year, Recursion has increased its headcount by over 60 per cent. Through this growth, Recursion lived its values by helping all Recursionauts navigate the pandemic while safely keeping its labs open, secured a transformational discovery partnership with a major biopharmaceutical company and debuted on the public markets, all to accelerate the company's progress toward achieving its mission. Recursion has initiated the office selection process in Toronto and plans to open the doors of its new hub in the fall. This multidisciplinary hub will join its Salt Lake City, Utah headquarters and Milpitas, California in vivo biology center.\n\"As a proud Canadian who was born and raised in Toronto, it's clear to me that Recursion's unique pace, scale, values and ambition are well aligned with the incredible talent in my hometown, making this a full-circle life moment...